Positron emission tomography imaging in the thorax.

[1]  M. Mandelkern,et al.  Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. , 1996, American journal of respiratory and critical care medicine.

[2]  A. Rikli,et al.  Solitary pulmonary nodules found in a community-wide chest roentgenographic survey; a five-year follow-up study. , 1959, American review of tuberculosis.

[3]  C A GOOD,et al.  The solitary circumscribed pulmonary nodule; study of seven hundred five cases encountered roentgenologically in a period of three and one-half years. , 1958, Journal of the American Medical Association.

[4]  M. Burt,et al.  Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Baamonde,et al.  Extrathoracic staging of bronchogenic carcinoma. , 1990, Chest.

[6]  M Fujita,et al.  CT-pathologic correlation in small peripheral lung cancers. , 1987, AJR. American journal of roentgenology.

[7]  V. Lowe,et al.  Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. , 1995, Chest.

[8]  A. Little,et al.  Clinical staging of patients with non-small cell lung cancer. , 1990, Chest.

[9]  Stitik Fp.  Staging of lung cancer. , 1990, The Radiologic clinics of North America.

[10]  G. V. von Schulthess,et al.  Detection of extrathoracic metastases by positron emission tomography in lung cancer. , 1998, The Annals of thoracic surgery.

[11]  David J. Yang,et al.  Detecting recurrent or residual lung cancer with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  L G Strauss,et al.  The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  J Bogaert,et al.  Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Coleman,et al.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.

[15]  M E Phelps,et al.  Whole-Body Positron Emission Tomography and Fluorodeoxyglucose , 2006 .

[16]  N. Gupta,et al.  Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose , 1994 .

[17]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[18]  Scott T. Grafton,et al.  PET and [18F]-FDG in oncology: a clinical update. , 1996, Nuclear medicine and biology.

[19]  R. Coleman,et al.  Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. , 1997, AJR. American journal of roentgenology.

[20]  K F Hübner,et al.  Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images. , 1996, Clinical nuclear medicine.

[21]  J. Gurney.  Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. , 1993, Radiology.

[22]  R. Hooper,et al.  Computed tomographic scanning of the brain in initial staging of bronchogenic carcinoma. , 1984, Chest.

[23]  L. Sider.  Radiographic manifestations of primary bronchogenic carcinoma. , 1990, Radiologic clinics of North America.

[24]  K. Ishiwata,et al.  Positron Emission Tomography for Treatment Evaluation and Recurrence Detection Compared with CT in Long-Term Follow-up Cases of Lung Cancer , 1992, Clinical nuclear medicine.

[25]  T. Shields,et al.  The solitary pulmonary nodule. Ten-year follow-up of veterans administration-armed forces cooperative study. , 1975, Archives of surgery.

[26]  E H Moore,et al.  Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. , 1992, Radiology.

[27]  P. Valk,et al.  Analytical decision model for the cost-effective management of solitary pulmonary nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  G. V. von Schulthess,et al.  Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. , 1997, Radiology.

[29]  N. Müller,et al.  Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. , 1991, Radiology.

[30]  J. Pagani.  Non‐small cell lung carcinoma adrenal metastases computed tomography and percutaneous needle biopsy in their diagnosis , 1984, Cancer.

[31]  A. Celler,et al.  Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography. , 1997, AJR. American journal of roentgenology.

[32]  D. E. Jackson,et al.  Staging of non-small cell bronchogenic carcinoma. Relationship of the clinical evaluation to organ scans. , 1986, Chest.

[33]  E A Zerhouni,et al.  CT of the solitary pulmonary nodule. , 1980, AJR. American journal of roentgenology.

[34]  L. Quint,et al.  Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. , 1988, Radiology.

[35]  K. Shaffer.  Imaging and medical staging of lung cancer. , 1997, Hematology/oncology clinics of North America.

[36]  S J Swensen,et al.  Lung nodule enhancement at CT: prospective findings. , 1996, Radiology.

[37]  M. Knopp,et al.  Clinical utility of positron emission tomography with FDG for chemotherapy response monitoring: A correlative study of patients with small cell lung cancer , 1994 .

[38]  P C Goodman,et al.  Evaluation of primary pulmonary carcinoid tumors using FDG PET. , 1998, AJR. American journal of roentgenology.

[39]  E. Buonocore,et al.  Characterization of Chest Masses by FDG Positron Emission Tomography , 1995, Clinical nuclear medicine.

[40]  M. Bernardino.  Management of the asymptomatic patient with a unilateral adrenal mass. , 1988, Radiology.

[41]  M. Korobkin,et al.  Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma. , 1982, AJR. American journal of roentgenology.

[42]  H. Asamura,et al.  Implications of staging in lung cancer. , 1997, Chest.

[43]  G. Salomon,et al.  Transthoracic needle biopsy with a coaxially placed 20-gauge automated cutting needle: results in 122 patients. , 1996, Radiology.

[44]  J. Hatazawa,et al.  Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer. , 1990, International journal of radiation oncology, biology, physics.

[45]  S. Swensen,et al.  Approach to the solitary pulmonary nodule. , 1993, Mayo Clinic proceedings.

[46]  Lillington Ga,et al.  Evaluation and management of solitary and multiple pulmonary nodules , 1993 .

[47]  F L Bookstein,et al.  Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. , 1985, AJR. American journal of roentgenology.

[48]  L. S. Broderick,et al.  Imaging of lung cancer: old and new. , 1997, Seminars in oncology.

[49]  S S Sagel,et al.  CT of the pulmonary nodule: a cooperative study. , 1986, Radiology.

[50]  J. Bishop,et al.  Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. , 1995, International journal of radiation oncology, biology, physics.

[51]  Webb Wr,et al.  The radiologic staging of lung cancer , 1991 .

[52]  Ben Wolepor.  The "American Review of Tuberculosis". , 1929, Canadian Medical Association journal.

[53]  J Konishi,et al.  Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT. , 1995, Radiology.

[54]  S S Gambhir,et al.  Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[55]  R. Wahl,et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.

[56]  R. Coleman,et al.  Pulmonary abnormalities and PET data analysis: a retrospective study. , 1997, Radiology.

[57]  S. Alexander.  Intracranial metastases in the initial staging of bronchogenic carcinoma. , 1984, Chest.

[58]  P. Marsden,et al.  Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer , 1994, The Lancet.

[59]  R Iwata,et al.  Differential diagnosis of lung tumor with positron emission tomography: a prospective study. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  R. R. Taylor,et al.  The solitary circumscribed pulmonary nodule. , 1957, A.M.A. archives of internal medicine.

[61]  T. Kuroki,et al.  Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[62]  J H Woodring,et al.  Significance of wall thickness in solitary cavities of the lung: a follow-up study. , 1983, AJR. American journal of roentgenology.

[63]  E. Rosenow,et al.  Evaluation and management of solitary and multiple pulmonary nodules. , 1992, Clinics in chest medicine.

[64]  G. Comstock,et al.  Outcome of solitary pulmonary nodules discovered in an x-ray screening program. , 1956, The New England journal of medicine.

[65]  M P Frick,et al.  Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. , 1993, Chest.

[66]  D Delbeke,et al.  Prospective investigation of positron emission tomography in lung nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  V. M. Phillips,et al.  CT-guided adrenal biopsy: accuracy, safety, and indications. , 1985, AJR. American journal of roentgenology.

[68]  V. Lowe,et al.  Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. , 1994, Radiology.

[69]  L. Israël,et al.  Lung cancer : natural history, prognosis, and therapy , 1976 .

[70]  V. Chuang,et al.  Solitary cavities of the lung: diagnostic implications of cavity wall thickness. , 1980, AJR. American journal of roentgenology.

[71]  J. Pagani.  Normal adrenal glands in small cell lung carcinoma: CT-guided biopsy. , 1983, AJR. American journal of roentgenology.

[72]  J. Sunderland,et al.  Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1992, Radiology.

[73]  E. Gunel,et al.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[74]  E G Theros,et al.  1976 Caldwell Lecture: varying manifestation of peripheral pulmonary neoplasms: a radiologic-pathologic correlative study. , 1977, AJR. American journal of roentgenology.

[75]  D. Podoloff,et al.  Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. , 1992, Radiographics : a review publication of the Radiological Society of North America, Inc.

[76]  J. Beck,et al.  Does the mediastinum of patients with non-small cell lung cancer require histologic staging? Future standards for computed tomography. , 1991, The American review of respiratory disease.

[77]  E. Fishman,et al.  Solitary pulmonary nodules: CT assessment. , 1986, Radiology.

[78]  P. Valk,et al.  Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. , 1995, The Annals of thoracic surgery.

[79]  Lillington Ga.  Pulmonary nodules: solitary and multiple. , 1982, Clinics in chest medicine.

[80]  R. Whyte,et al.  Distribution of distant metastases from newly diagnosed non-small cell lung cancer. , 1996, The Annals of thoracic surgery.

[81]  K. Nackaerts,et al.  Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer - A prospective analysis of 50 cases , 1997 .

[82]  R. Wahl,et al.  Preoperative staging of non-small-cell carcinoma of the lung: imaging methods. , 1995, AJR. American journal of roentgenology.

[83]  R. Coleman,et al.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma , 1998, Cancer.

[84]  E. Fishman,et al.  Solitary bronchioloalveolar carcinoma: CT criteria. , 1988, Radiology.

[85]  Bronchogenic carcinoma: a survey of CT protocols for staging disease. , 1997, Academic radiology.

[86]  T. Fukumura,et al.  Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[87]  M. Bernardino,et al.  Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. , 1984, Radiology.

[88]  N. Dewan,et al.  Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. , 1997, Chest.

[89]  S. Reske,et al.  Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). , 1997, Thorax.

[90]  J. Dussek,et al.  Survival and prognosis following resection of primary non small cell bronchogenic carcinoma. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[91]  T. A. Smith,et al.  FDG uptake, tumour characteristics and response to therapy: A review , 1998, Nuclear medicine communications.